Thursday 24th February 2011
|Text too small?|
Christchurch-based medical supplies company Ebos Group has reported a 9.7% rise in interim operating earnings and says it has ample stock nationally to support Canterbury after Tuesday's earthquake.
"As a Christchurch-based company we are acutely aware of the impact of the devastating earthquake on the city, its people and businesses. Our sympathy is extended to everyone at this sad and difficult time," the company said at the outset of its interim profit release today. All of its staff based in Christchurch are safe.
"As a key supplier of pharmaceuticals and medical supplies we can assure continuity of supply to the region. Local distribution capability is being supplemented by our major regional distribution centres. We have ample stockholding nationally to support Canterbury," the company said.
Ebos reported earnings before interest, tax, depreciation and amortisation of $20.7 million in the six months to December 31, up 9.7% on a year ago. The net profit of $19.8 million was boosted by the sale of the scientific business and the profit from ongoing operations rose 12.6%.
Directors have declared a fully imputed interim dividend on 13.5 cents per share, payable on April 21. This is on top of the recent special dividend payment of 20 cents per share. The record date for the interim dividend is April 8.
The company said it was looking at projects and opportunities to drive growth.
No comments yet
18th October 2021 Morning Report
T&G Global Limited (NZX: TGG) FY21 Earnings Guidance Update
Arvida Group Limited (NZX: ARV) Successful Completion of $155m Placement
FreshLeaf: Cannabis on course to be 'medicine of the masses'
Arvida Group Limited (NZX: ARV) to Acquire Arena Living Retirement Living Portfolio
My Food Bag Group Limited (NZX: MFB) Market Update and HY Results Announcement Date
Harmoney Corp Limited (NZX: HMY) Delivers Record September Quarter
Vital Healthcare Property Trust (NZX: VHP) Announces Successful Completion of $115m Placement
14th October 2021 Morning Report
General Capital Limited (NZX: GEN) Completes Greenfern Listing